BIOMAT Database Logo BIOMAT Database Logo

[Combined adriamycin and 5-fluorouracil therapy in the treatment of advanced cancer of the bladder (author's transl)]. 1982

E Marcuello Gaspar, and J R Germá Lluch, and J Dorca Ribugent, and A López Pousa, and J Español Llorens, and A Abad Esteve, and A Avella Mestre

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E Marcuello Gaspar, and J R Germá Lluch, and J Dorca Ribugent, and A López Pousa, and J Español Llorens, and A Abad Esteve, and A Avella Mestre
Treatment of advanced bladder cancer with adriamycin and 5-fluorouracil.
January 1976, British journal of urology,
E Marcuello Gaspar, and J R Germá Lluch, and J Dorca Ribugent, and A López Pousa, and J Español Llorens, and A Abad Esteve, and A Avella Mestre
Advanced bladder cancer: therapy with cis-dichlorodiammineplatinum(II), adriamycin, and 5-fluorouracil.
January 1979, Cancer treatment reports,
E Marcuello Gaspar, and J R Germá Lluch, and J Dorca Ribugent, and A López Pousa, and J Español Llorens, and A Abad Esteve, and A Avella Mestre
[Adriamycin, cyclophosphamide, and 5-fluorouracil in the treatment of metastasizing breast cancer (author's transl)].
June 1976, Zeitschrift fur Krebsforschung und klinische Onkologie. Cancer research and clinical oncology,
E Marcuello Gaspar, and J R Germá Lluch, and J Dorca Ribugent, and A López Pousa, and J Español Llorens, and A Abad Esteve, and A Avella Mestre
Combination chemotherapy for advanced bladder cancer with adriamycin, cyclophosphamide, and 5-fluorouracil.
January 1983, Cancer chemotherapy and pharmacology,
E Marcuello Gaspar, and J R Germá Lluch, and J Dorca Ribugent, and A López Pousa, and J Español Llorens, and A Abad Esteve, and A Avella Mestre
Combination chemotherapy with adriamycin and 5-fluorouracil in advanced bladder carcinoma.
June 1982, Clinical oncology,
E Marcuello Gaspar, and J R Germá Lluch, and J Dorca Ribugent, and A López Pousa, and J Español Llorens, and A Abad Esteve, and A Avella Mestre
The treatment of advanced carcinoma of the bladder with a combination of adriamycin and 5-fluorouracil.
January 1977, European urology,
E Marcuello Gaspar, and J R Germá Lluch, and J Dorca Ribugent, and A López Pousa, and J Español Llorens, and A Abad Esteve, and A Avella Mestre
[Co-administration of adriamycin and 5-fluorouracil for the treatment of advanced stomach cancer].
April 1983, Gan to kagaku ryoho. Cancer & chemotherapy,
E Marcuello Gaspar, and J R Germá Lluch, and J Dorca Ribugent, and A López Pousa, and J Español Llorens, and A Abad Esteve, and A Avella Mestre
5-Fluorouracil, adriamycin and cyclophosphamide combined with high-dose medroxyprogesterone acetate in advanced breast cancer.
December 1983, Tumori,
E Marcuello Gaspar, and J R Germá Lluch, and J Dorca Ribugent, and A López Pousa, and J Español Llorens, and A Abad Esteve, and A Avella Mestre
[Polychemotherapy treatment with cisplatin, adriamycin, 5-fluorouracil (FAP) and cisplatin, adriamycin and cyclophosphamide (CISCA) in advanced transitional carcinoma of the bladder].
January 1989, Actas urologicas espanolas,
E Marcuello Gaspar, and J R Germá Lluch, and J Dorca Ribugent, and A López Pousa, and J Español Llorens, and A Abad Esteve, and A Avella Mestre
Treatment of advanced gastric cancer with DDP (cisplatin), adriamycin, and 5-fluorouracil (DAF).
January 1987, Oncology,
Copied contents to your clipboard!